Table 1. Association between miR-27a protein expression and clinicopathological features of patients with BC.
| Clinicopathological feature | Case | miR-27a protein expression | P |
|---|---|---|---|
| Age of onset | 0.337 | ||
| ≤ 55 years old | 217 | 2.056 ± 0.710 | |
| > 55 years old | 179 | 2.126 ± 0.735 | |
| Menstruation condition | 0.450 | ||
| Premenopausal | 211 | 2.062 ± 0.708 | |
| Postmenopausal | 185 | 2.117 ± 0.737 | |
| Clinical stages | < 0.001 | ||
| I stage | 38 | 1.381 ± 0.093 | |
| II stage | 235 | 1.817 ± 0.647 | |
| III stage | 123 | 2.823 ± 0.192 | |
| Tumor size | < 0.001 | ||
| ≤ 2 cm | 207 | 1.862 ± 0.246 | |
| > 2 cm | 189 | 1.921 ± 0.240 | |
| Lymph node metastasis | < 0.001 | ||
| Yes | 186 | 2.808 ± 0.228 | |
| No | 210 | 1.450 ± 0.259 | |
| Distant metastasis | < 0.001 | ||
| Yes | 118 | 2.857 ± 0.065 | |
| No | 278 | 1.761 ± 0.618 |
Note: miR-27a, microRNA-27a; BC, breast cancer.